Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95.5M
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
16.2M
-
Shares change
-
+1.01M
-
Total reported value, excl. options
-
$251M
-
Value change
-
+$15.1M
-
Put/Call ratio
-
1.83
-
Number of buys
-
26
-
Number of sells
-
-43
-
Price
-
$15.47
Significant Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q2 2021
86 filings reported holding CLLS - Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share as of Q2 2021.
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.2M shares
of 95.5M outstanding shares and own 16.98% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (4.66M shares), Capital International Investors (1.34M shares), PRINCIPAL FINANCIAL GROUP INC (1.26M shares), CREDIT SUISSE AG/ (1.2M shares), BAILLIE GIFFORD & CO (1.03M shares), CAPITAL INTERNATIONAL INC /CA/ (876K shares), Capital World Investors (875K shares), Sumitomo Mitsui Trust Holdings, Inc. (795K shares), Nikko Asset Management Americas, Inc. (787K shares), and Bpifrance SA (426K shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.